Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life. Final recommendations from the National Institute for Health and Care Excellence (NICE) mean children over the age of 12 months, who have responded to previous treatment but have a high risk of their cancer coming back, will